Therapeutic advances in psychopharmacology

Keyphrases

Publications

volume 14, 2024

Bradley G Burk, Kyle Humphreys, Jim Waites, Bentley Adams, Badari Birur, Pamela E Parker
Sublingual asenapine for agitation in malabsorptive states: three patient cases. Therapeutic advances in psychopharmacology 14 (2024)
Eduardo Ekman Schenberg
Psychedelic skepticism: back to the sixties? Therapeutic advances in psychopharmacology 14 (2024)
Yu-Ting Li, Chi Zhang, Jia-Cheng Han, Yu-Xuan Shang, Zhu-Hong Chen, Guang-Bin Cui, Wen Wang
Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder. Therapeutic advances in psychopharmacology 14 (2024)
Rajesh R Tampi, Jordan F Karp
Geriatric psychiatry and brain health in old age. Therapeutic advances in psychopharmacology 14 (2024)
Raymond Yan, Tyler Marshall, Atul Khullar, Travis Nagle, Jake Knowles, Mai Malkin, Brittany Chubbs, Jennifer Swainson
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression. Therapeutic advances in psychopharmacology 14 (2024)
Sofia Brissos, Vicent Balanzá-Martínez
Long-acting antipsychotic treatments: focus on women with schizophrenia. Therapeutic advances in psychopharmacology 14 (2024)
David M Taylor, Sofia Poulou, Ivana Clark
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use. Therapeutic advances in psychopharmacology 14 (2024)
Geke van Weringh, Leonieke van Koolwijk, Lieuwe de Haan, Daan J Touw, Mariken B de Koning
Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report. Therapeutic advances in psychopharmacology 14 (2024)
Hui Ouyang, Lili Wu, Wenjie Yan, Keyi Si, Hongli Lv, Jingye Zhan, Jing Wang, Yanpu Jia, Zhilei Shang, Wenfang Chen, Weizhi Liu
Network analysis of the comorbidity between post-traumatic stress, depression and anxiety symptoms among frontline healthcare workers during the COVID-19 pandemic. Therapeutic advances in psychopharmacology 14 (2024)
Guanghui Deng, Chenwei Huang, Wenjie Yan, Hui Ouyang, Weizhi Liu
Attentional bias modification and attention control training in PTSD: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Hui Ouyang, Lili Wu, Wenjie Yan, Keyi Si, Hongli Lv, Jingye Zhan, Jing Wang, Yanpu Jia, Zhilei Shang, Wenfang Chen, Weizhi Liu
Network analysis of the comorbidity between post-traumatic stress, depression and anxiety symptoms among frontline healthcare workers during the COVID-19 pandemic. Therapeutic advances in psychopharmacology 14 (2024)
Jasmina Mallet, Clément Dondé, Caroline Dubertret, Philip Gorwood
Patients' awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics. Therapeutic advances in psychopharmacology 14 (2024)
Coralie Creupelandt, Emilie Veerapa, Arnaud Bugnet, Marielle Wathelet, Alice Demesmaeker, Pierre Grandgenevre, Guillaume Vaiva, Thomas Fovet, Fabien D'Hondt
Comment on: Attentional bias modification and attention control training in PTSD: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Baeleigh VanderZwaag, Albert Garcia-Romeu, Mauricio A Garcia-Barrera
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery. Therapeutic advances in psychopharmacology 14 (2024)
James R O'Neill, David M Taylor, Mark A Horowitz
Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs. Therapeutic advances in psychopharmacology 14 (2024)
Ou Yu, Mengyao Lu, Terence K Y Lai, Margaret Hahn, Sri Mahavir Agarwal, Brian O'Donoghue, Bjørn H Ebdrup, Dan J Siskind
Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Geke van Weringh, Leonieke van Koolwijk, Lieuwe de Haan, Daan J Touw, Mariken B de Koning
Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report. Therapeutic advances in psychopharmacology 14 (2024)
Yu-Ting Li, Chi Zhang, Jia-Cheng Han, Yu-Xuan Shang, Zhu-Hong Chen, Guang-Bin Cui, Wen Wang
Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder. Therapeutic advances in psychopharmacology 14 (2024)
Nadia El Ouni Amami, Husen Ali-Diabacte, Sarra Ateb, Hamadi Ben Rejeb, Avicenne Bellis, Reza Bellis, Dominique Januel, Noomane Bouaziz
Clozapine-induced cholinergic urticaria: a case report. Therapeutic advances in psychopharmacology 14 (2024)
Raúl Sancho-Echeverria, Claudia Aymerich, José Manuel Rodríguez-Sánchez, Patxi Gil, Borja Pedruzo, Miguel Ángel González-Torres, Paolo Fusar-Poli, Celso Arango, Ana Catalán
Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study. Therapeutic advances in psychopharmacology 14 (2024)
Guanghui Deng, Chenwei Huang, Wenjie Yan, Hui Ouyang, Weizhi Liu
Attentional bias modification and attention control training in PTSD: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Guanghui Deng, Chenwei Huang, Wenjie Yan, Hui Ouyang, Weizhi Liu
Attentional bias modification and attention control training in PTSD: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Hui Ouyang, Lili Wu, Wenjie Yan, Keyi Si, Hongli Lv, Jingye Zhan, Jing Wang, Yanpu Jia, Zhilei Shang, Wenfang Chen, Weizhi Liu
Network analysis of the comorbidity between post-traumatic stress, depression and anxiety symptoms among frontline healthcare workers during the COVID-19 pandemic. Therapeutic advances in psychopharmacology 14 (2024)
Sebastian Schröder, Martin Schulze Westhoff, Tabea Pfister, Johanna Seifert, Stefan Bleich, Felix Koop, Phileas Johannes Proskynitopoulos, Alexander Glahn, Johannes Heck
Drug safety in older patients with alcohol use disorder: a retrospective cohort study. Therapeutic advances in psychopharmacology 14 (2024)
Sebastian Schröder, Martin Schulze Westhoff, Tabea Pfister, Johanna Seifert, Stefan Bleich, Felix Koop, Phileas Johannes Proskynitopoulos, Alexander Glahn, Johannes Heck
Drug safety in older patients with alcohol use disorder: a retrospective cohort study. Therapeutic advances in psychopharmacology 14 (2024)
Raúl Sancho-Echeverria, Claudia Aymerich, José Manuel Rodríguez-Sánchez, Patxi Gil, Borja Pedruzo, Miguel Ángel González-Torres, Paolo Fusar-Poli, Celso Arango, Ana Catalán
Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study. Therapeutic advances in psychopharmacology 14 (2024)
Shijin Wu, Yuyang Zhou
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review. Therapeutic advances in psychopharmacology 14 (2024)
Bradley G Burk, Kyle Humphreys, Jim Waites, Bentley Adams, Badari Birur, Pamela E Parker
Sublingual asenapine for agitation in malabsorptive states: three patient cases. Therapeutic advances in psychopharmacology 14 (2024)
Rebecca Henry, David S Baldwin
Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomes. Therapeutic advances in psychopharmacology 14 (2024)
Eduardo Ekman Schenberg
Psychedelic skepticism: back to the sixties? Therapeutic advances in psychopharmacology 14 (2024)
Baeleigh VanderZwaag, Albert Garcia-Romeu, Mauricio A Garcia-Barrera
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery. Therapeutic advances in psychopharmacology 14 (2024)
Eduardo Ekman Schenberg
Psychedelic skepticism: back to the sixties? Therapeutic advances in psychopharmacology 14 (2024)
Sofia Brissos, Vicent Balanzá-Martínez
Long-acting antipsychotic treatments: focus on women with schizophrenia. Therapeutic advances in psychopharmacology 14 (2024)
Nadia El Ouni Amami, Husen Ali-Diabacte, Sarra Ateb, Hamadi Ben Rejeb, Avicenne Bellis, Reza Bellis, Dominique Januel, Noomane Bouaziz
Clozapine-induced cholinergic urticaria: a case report. Therapeutic advances in psychopharmacology 14 (2024)
David M Taylor, Sofia Poulou, Ivana Clark
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use. Therapeutic advances in psychopharmacology 14 (2024)
Giovanni Vita, Angelantonio Tavella, Giovanni Ostuzzi, Federico Tedeschi, Michele De Prisco, Rafael Segarra, Marco Solmi, Corrado Barbui, Christoph U Correll
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Ou Yu, Mengyao Lu, Terence K Y Lai, Margaret Hahn, Sri Mahavir Agarwal, Brian O'Donoghue, Bjørn H Ebdrup, Dan J Siskind
Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Giovanni Vita, Angelantonio Tavella, Giovanni Ostuzzi, Federico Tedeschi, Michele De Prisco, Rafael Segarra, Marco Solmi, Corrado Barbui, Christoph U Correll
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 14 (2024)
Raúl Sancho-Echeverria, Claudia Aymerich, José Manuel Rodríguez-Sánchez, Patxi Gil, Borja Pedruzo, Miguel Ángel González-Torres, Paolo Fusar-Poli, Celso Arango, Ana Catalán
Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study. Therapeutic advances in psychopharmacology 14 (2024)
Raymond Yan, Tyler Marshall, Atul Khullar, Travis Nagle, Jake Knowles, Mai Malkin, Brittany Chubbs, Jennifer Swainson
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression. Therapeutic advances in psychopharmacology 14 (2024)
Jasmina Mallet, Clément Dondé, Caroline Dubertret, Philip Gorwood
Patients' awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics. Therapeutic advances in psychopharmacology 14 (2024)
Shijin Wu, Yuyang Zhou
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review. Therapeutic advances in psychopharmacology 14 (2024)

volume 13, 2023

Na Zhou, Chengchuan Chen, Yubei Liu, Zhaolan Yu, Yanhua Chen
Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology 13 (2023)
Sarah T Stahl, Joelle Kincman, Jordan F Karp, Marie Anne Gebara
Psychosocial interventions to improve adherence in depressed and anxious older adults prescribed antidepressant pharmacotherapy: a scoping review. Therapeutic advances in psychopharmacology 13 (2023)
Ibrahim Turkoz, Joshua Wong, Benjamin Chee, Uzma Siddiqui, R Karl Knight, Ute Richarz, Christoph U Correll
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia. Therapeutic advances in psychopharmacology 13 (2023)
Farhan Fancy, Sipan Haikazian, Danica E Johnson, David C J Chen-Li, Anastasia Levinta, Muhammad I Husain, Rodrigo B Mansur, Joshua Daniel Rosenblat
Ketamine for bipolar depression: an updated systematic review. Therapeutic advances in psychopharmacology 13 (2023)
Lisanne Koomen, Ilona van de Meent, Floor Elferink, Ingeborg Wilting, Wiepke Cahn
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness. Therapeutic advances in psychopharmacology 13 (2023)
Caiji Zheng, Haiyan Liu, Weifeng Tu, Lingyun Lin, Haiyun Xu
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications. Therapeutic advances in psychopharmacology 13 (2023)
Michiel van Elk, Eiko I Fried
History repeating: guidelines to address common problems in psychedelic science. Therapeutic advances in psychopharmacology 13 (2023)
Morgan Faeder, Elizabeth Hale, Daniel Hedayati, Alex Israel, Darcy Moschenross, Melanie Peterson, Ryan Peterson, Mariel Piechowicz, Jonathan Punzi, Priya Gopalan
Preventing and treating delirium in clinical settings for older adults. Therapeutic advances in psychopharmacology 13 (2023)